Moolec Science has secured a US patent for its Piggy Sooy technology, a genetically engineered soybean able to produce high levels of porcine hemeproteins in its seeds. The patent covers plants, seeds, development methods, and food compositions derived from this technology, showcasing Moolec's expertise in Molecular Farming. Field trials have shown promising results, with the technology producing over 20% animal protein content in the soluble protein fraction, offering significant environmental benefits compared to traditional meat production.
This patent provides Moolec with exclusive commercial rights for Piggy Sooy in the US until 2042, with additional patent applications filed globally. The company, recently merged with Bioceres Group, is leading innovation in sustainable protein production by combining molecular farming with biological agricultural technologies. The appointment of a new CEO, Alejandro Antalich, emphasizes Moolec's commitment to advancing towards commercialization and establishing a unique position in the food and feed ingredients market.
*This summary was generated using AI.
Read Full Article